WBP1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of the WBP1 (WW domain-binding protein 1) protein. WBP1 is known for its interaction with WW domain-containing proteins, which are involved in mediating protein-protein interactions through recognition of proline-rich motifs. These interactions are critical for several cellular processes, including signal transduction, protein degradation, and the regulation of transcriptional activity. WBP1 serves as an adaptor protein, facilitating the assembly of multiprotein complexes that are essential for coordinating cellular communication and the regulation of various signaling pathways. Inhibitors targeting WBP1 disrupt its ability to bind to WW domain-containing proteins, which can interfere with the downstream processes dependent on these interactions.
The mechanism of action of WBP1 inhibitors involves binding to the regions of WBP1 responsible for interacting with WW domain proteins, thus blocking its ability to form functional complexes. This disruption alters key pathways related to protein ubiquitination, cellular signaling, and transcriptional regulation, all of which rely on the proper function of WBP1 and its associated proteins. Researchers use WBP1 inhibitors to study the precise roles of this protein in maintaining cellular signaling networks, providing insights into how WBP1-mediated interactions affect broader biological processes. By inhibiting WBP1, these compounds help to elucidate the mechanisms by which protein-protein interactions regulate cellular communication and maintain homeostasis, offering a deeper understanding of the molecular networks that coordinate protein stability, gene expression, and signal transduction within cells.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Inhibits a broad range of protein kinases, possibly affecting kinase-related signaling pathways that WBP1 may be involved in. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, possibly affecting the synthesis of WBP1. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus, potentially impacting the trafficking of WBP1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Inhibits protein tyrosine kinases, possibly affecting phosphorylation events that WBP1 may be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, possibly disrupting signaling cascades that modulate WBP1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK1/2, possibly affecting the MAPK/ERK pathway and thus the function of WBP1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which could affect protein synthesis and other cellular processes that WBP1 may regulate. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially affecting signaling pathways and subsequent protein interactions with WBP1. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II, possibly disrupting signaling pathways that WBP1 is part of. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, potentially affecting stress response signaling pathways involving WBP1. | ||||||